QA: Viracta Therapeutics Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001061027_2014_Viracta_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001061027, Viracta Therapeutics Inc

  xvar xval
0 AssetsCurrent 40,492,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 23,000
3 remainder_Assets 10,000
4 LiabilitiesCurrent 33,972,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,838,000
9 ResearchAndDevelopmentExpense 28,891,000
10 remainder_Expenses 2,917,000
11 remainder_Revenues 7,956,000
12 remainder_NetIncome 92,000
13 remainder_ComprehensiveNetIncome -41,000
  yvar yval
0 Assets 40,525,000
1 Liabilities 33,972,000
2 Expenses 42,646,000
3 Revenues 7,956,000
4 StockholdersEquity 6,553,000
5 NetIncome -34,598,000
6 ComprehensiveNetIncome -34,618,500
7 BaseVar 62,616,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.546
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution

Change over Time